Seminars in Hematology
Volume 45 , Pages S50-S57 , April 2008

Blood-Induced Joint Disease: The Confluence of Dysregulated Oncogenes, Inflammatory Signals, and Angiogenic Cues

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Leonard Valentino has received grants/research support from Novo Nordisk, Baxter Bioscience, Bayer Healthcare, GlaxoSmithKline, Wyeth, and CSL Behring. He has also served as an advisory board member/consultant for Novo Nordisk, Baxter Bioscience, Wyeth, and CSL Behring, and has served on a speakers' bureau or as a faculty member for Novo Nordisk and Wyeth. Narine Hakobyan has received grant funding from CSL Behring Foundation. Candace Enockson declares no conflict of interest.

PII: S0037-1963(08)00057-7

doi: 10.1053/j.seminhematol.2008.03.017

Seminars in Hematology
Volume 45 , Pages S50-S57 , April 2008

Article Tools

* Image Usage & Resolution